Advertisement

Related Videos

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Varsha Gandhi, PhD, on Ibrutinib

David A. Hyman, MD, JD, on Inclusive Shared Savings

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Advertisement

Advertisement




Apr
16
Today In Oncology
Is Standard of Care Optimal for the Individual Patient?
LuPSMA-617 and Pembrolizumab in mCRPC
ASH-ISTH Create Guidelines for Pediatric VTE Prophylaxis
Asbestos-Free Talc Not Associated With Increased Risk for Respiratory Cancers
New Molecular-Based Model for Classification and Risk in Chronic Myelomonocytic Leukemia
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo